Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The reliability of two prospective cortical biomarkers for pain: EEG peak alpha frequency and TMS corticomotor excitability

View ORCID ProfileNahian S Chowdhury, Patrick Skippen, E Si, Alan Chiang, Samantha K Millard, Andrew J Furman, Shuo Chen, David A Seminowicz, Siobhan M Schabrun
doi: https://doi.org/10.1101/2022.03.06.22271797
Nahian S Chowdhury
1Center for Pain IMPACT, Neuroscience Research Australia, Sydney, New South Wales, Australia
2University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nahian S Chowdhury
  • For correspondence: n.chowdhury@neura.edu.au
Patrick Skippen
1Center for Pain IMPACT, Neuroscience Research Australia, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Si
1Center for Pain IMPACT, Neuroscience Research Australia, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Chiang
1Center for Pain IMPACT, Neuroscience Research Australia, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha K Millard
1Center for Pain IMPACT, Neuroscience Research Australia, Sydney, New South Wales, Australia
2University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J Furman
3Department of Neural and Pain Sciences, University of Maryland School of Dentistry, Baltimore, MD, 21201
4Center to Advance Chronic Pain Research, University of Maryland Baltimore, Baltimore, MD, 21201
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuo Chen
3Department of Neural and Pain Sciences, University of Maryland School of Dentistry, Baltimore, MD, 21201
4Center to Advance Chronic Pain Research, University of Maryland Baltimore, Baltimore, MD, 21201
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A Seminowicz
3Department of Neural and Pain Sciences, University of Maryland School of Dentistry, Baltimore, MD, 21201
4Center to Advance Chronic Pain Research, University of Maryland Baltimore, Baltimore, MD, 21201
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siobhan M Schabrun
1Center for Pain IMPACT, Neuroscience Research Australia, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Many pain biomarkers fail to move from discovery to clinical application, attributed to poor reliability and feasible classifications of at-risk individuals. Preliminary evidence has shown that higher pain sensitivity is associated with slow peak alpha frequency (PAF) and depression of corticomotor excitability (CME). The present study evaluated the reliability of these measures, specifically whether, over several days of pain, a) PAF remains stable and b) individuals show two stable and distinct CME responses: facilitation and depression. Seventy-five healthy participants were given an injection of nerve growth factor (NGF) into the right masseter muscle on Day 0 and Day 2, inducing sustained pain. Electroencephalography (EEG) to assess PAF and transcranial magnetic stimulation (TMS) to assess CME were recorded on Day 0, Day 2 and Day 5. PAF reliability was in the excellent range even without standard pre-processing and ∼2 minutes recording length. Moreover, two distinct and stable CME responses were demonstrated: facilitation and depression. These findings support the notion that PAF is a stable trait characteristic, with reliability unaffected by pain, and excellent reliability achievable with minimal pre-processing and ∼2 minutes recording, making it a readily translatable biomarker. Furthermore, the study showed novel evidence of two stable corticomotor adaptations to sustained pain. Overall, the study provides support for the reliability of PAF and CME as prospective cortical biomarkers.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04241562

Funding Statement

Thus study was funded by the National Institutes of Health (R61 NS113269/NS/NINDS NIH HHS/United States)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics Committee of University of New South Wales gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Disclosures The authors have no conflicts to declare.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 07, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The reliability of two prospective cortical biomarkers for pain: EEG peak alpha frequency and TMS corticomotor excitability
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The reliability of two prospective cortical biomarkers for pain: EEG peak alpha frequency and TMS corticomotor excitability
Nahian S Chowdhury, Patrick Skippen, E Si, Alan Chiang, Samantha K Millard, Andrew J Furman, Shuo Chen, David A Seminowicz, Siobhan M Schabrun
medRxiv 2022.03.06.22271797; doi: https://doi.org/10.1101/2022.03.06.22271797
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The reliability of two prospective cortical biomarkers for pain: EEG peak alpha frequency and TMS corticomotor excitability
Nahian S Chowdhury, Patrick Skippen, E Si, Alan Chiang, Samantha K Millard, Andrew J Furman, Shuo Chen, David A Seminowicz, Siobhan M Schabrun
medRxiv 2022.03.06.22271797; doi: https://doi.org/10.1101/2022.03.06.22271797

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pain Medicine
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (506)
  • Anesthesia (110)
  • Cardiovascular Medicine (1244)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (532)
  • Epidemiology (10027)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2462)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1645)
  • Health Policy (753)
  • Health Systems and Quality Improvement (636)
  • Hematology (250)
  • HIV/AIDS (535)
  • Infectious Diseases (except HIV/AIDS) (11871)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (253)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2289)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1248)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (733)
  • Pharmacology and Therapeutics (314)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4840)
  • Radiology and Imaging (838)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (651)
  • Rheumatology (286)
  • Sexual and Reproductive Health (240)
  • Sports Medicine (227)
  • Surgery (268)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)